Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, Bari, Italy.
Psychol Med. 2023 Aug;53(11):5235-5245. doi: 10.1017/S0033291722002288. Epub 2022 Aug 25.
Altered cerebral blood flow (CBF) has been found in people at risk for psychosis, with first-episode psychosis (FEP) and with chronic schizophrenia (SCZ). Studies using arterial spin labelling (ASL) have shown reduction of cortical CBF and increased subcortical CBF in SCZ. Previous studies have investigated CBF using ASL in FEP, reporting increased CBF in striatum and reduced CBF in frontal cortex. However, as these people were taking antipsychotics, it is unclear whether these changes are related to the disorder or antipsychotic treatment and how they relate to treatment response.
We examined CBF in FEP free from antipsychotic medication ( = 21), compared to healthy controls ( = 22). Both absolute and relative-to-global CBF were assessed. We also investigated the association between baseline CBF and treatment response in a partially nested follow-up study ( = 14).
There was significantly lower absolute CBF in frontal cortex (Cohen's = 0.84, = 0.009) and no differences in striatum or hippocampus. Whole brain voxel-wise analysis revealed widespread cortical reductions in absolute CBF in large cortical clusters that encompassed occipital, parietal and frontal cortices (Threshold-Free Cluster Enhancement (TFCE)-corrected <0.05). No differences were found in relative-to-global CBF in the selected region of interests and in voxel-wise analysis. Relative-to-global frontal CBF was correlated with percentage change in total Positive and Negative Syndrome Scale after antipsychotic treatment ( = 0.67, = 0.008).
These results show lower cortical absolute perfusion in FEP prior to starting antipsychotic treatment and suggest relative-to-global frontal CBF as assessed with magnetic resonance imaging could potentially serve as a biomarker for antipsychotic response.
在有精神病风险的人群、首发精神病(FEP)和慢性精神分裂症(SCZ)患者中,已发现脑血流(CBF)改变。使用动脉自旋标记(ASL)的研究表明,SCZ 患者皮质 CBF 减少,皮质下 CBF 增加。以前的研究使用 ASL 研究了 FEP 中的 CBF,报告纹状体 CBF 增加,额皮质 CBF 减少。然而,由于这些人正在服用抗精神病药物,因此尚不清楚这些变化是与疾病还是抗精神病药物治疗有关,以及它们与治疗反应的关系如何。
我们检查了未服用抗精神病药物的 FEP 患者(n = 21)和健康对照组(n = 22)的 CBF。评估了绝对和相对全局 CBF。我们还在部分嵌套的随访研究中调查了基线 CBF 与治疗反应之间的关系(n = 14)。
额皮质的绝对 CBF 明显较低(Cohen's = 0.84,p = 0.009),纹状体和海马体无差异。全脑体素分析显示,在包含枕叶、顶叶和额叶皮质的大皮质簇中,绝对 CBF 广泛减少(经阈值自由聚类增强(TFCE)校正的<0.05)。在选定的感兴趣区域和体素分析中,未发现相对全局 CBF 存在差异。相对全局额皮质 CBF 与抗精神病治疗后阳性和阴性综合征量表总分的变化百分比相关(r = 0.67,p = 0.008)。
这些结果表明,在开始抗精神病治疗之前,FEP 患者的皮质绝对灌注较低,并且表明使用磁共振成像评估的相对全局额皮质 CBF 可能作为抗精神病反应的生物标志物。